Long-term follow-up of patients with NAFLD and elevated liver enzymes
about
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individualsNon-alcoholic fatty liver disease: what the clinician needs to know.Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemicNon-alcoholic fatty liver disease and mortality among US adults: prospective cohort studyPioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitisNonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and managementCytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation studyA Guide to Non-Alcoholic Fatty Liver Disease in Childhood and AdolescenceThe Natural Course of Non-Alcoholic Fatty Liver DiseaseInsulin resistance in development and progression of nonalcoholic fatty liver diseaseNon-Alcoholic Fatty Liver Disease and Extra-Hepatic CancersVascular Damage in Patients with Nonalcoholic Fatty Liver Disease: Possible Role of Iron and FerritinNAFLD and Increased Aortic Stiffness: Parallel or Common Physiopathological Mechanisms?A Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLDType 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the SpotlightBidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic SyndromeChemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agentsMechanisms of intrahepatic triglyceride accumulationResearch advances in the relationship between nonalcoholic fatty liver disease and atherosclerosisTreatment of Nonalcoholic Fatty Liver Disease: The Role of Medical, Surgical, and Endoscopic Weight LossComorbidities and Metabolic Derangement of NAFLDLiver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance.Endocrine causes of nonalcoholic fatty liver diseaseNonalcoholic Fatty Liver Disease: Dyslipidemia, Risk for Cardiovascular Complications, and Treatment StrategyNon-Alcoholic Steatohepatitis: Limited Available Treatment Options but Promising Drugs in Development and Recent Progress Towards a Regulatory Approval PathwayThe role of ursodeoxycholic acid in non-alcoholic steatohepatitis: a systematic reviewManagement of dyslipidemia as a cardiovascular risk factor in individuals with nonalcoholic fatty liver diseaseComposite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countriesNon-alcoholic fatty liver disease: what has changed in the treatment since the beginning?Dietary habits and behaviors associated with nonalcoholic fatty liver diseaseNon-alcoholic fatty liver disease and diabetes: from physiopathological interplay to diagnosis and treatmentCardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An updateDiagnosis and management of non-alcoholic fatty liver disease and related metabolic disorders: consensus statement from the Study Group of Liver and Metabolism, Chinese Society of EndocrinologyNon-alcoholic fatty liver disease: a practical approach to diagnosis and stagingPsychological and psychiatric aspects of treatment of obesity and nonalcoholic fatty liver diseaseNonalcoholic fatty liver disease: new treatmentsLipid-lowering agents in the management of nonalcoholic fatty liver diseaseIntestinal activation of Notch signaling induces rapid onset hepatic steatosis and insulin resistanceNonalcoholic fatty liver disease and vascular disease: state-of-the-art.Molecular Pathogenesis of NASH
P2860
Q22299426-39ADCC9E-43EA-47EE-AF7F-4DF19590A5EEQ24563068-DFA112D1-892E-423D-A353-440755CFCE85Q24563381-71FA81DD-1DFC-4F62-BA7D-B58A4448EA8DQ24596256-6191C6B3-C652-49DA-A5C5-85B0FB0394CAQ24625697-55F1AE77-4924-4D87-B412-2FDCC914D83EQ24649618-333226E8-4BF4-4C16-B52A-D927AEBC5AEAQ24657221-ECC8D170-9A59-4A82-8FC3-B80EFBF78583Q26744488-61189C78-3B3E-4D25-BFF2-1ADD71EA8813Q26746947-38BE8AF3-8ED3-4147-A30E-8EACD126F5E7Q26748687-C1AB1A6E-BBDF-4C27-B33D-8A59933C0887Q26749045-819F2B11-5D58-4C40-983A-E977305DBC32Q26750865-EA1976C7-10C7-4E5D-814A-BCCA50A90617Q26750955-4F4547EC-1665-4484-AB9D-5C15DC448E14Q26752487-06469140-FCAB-4960-99D8-1B16C5DB0FE9Q26752583-C440F03F-9499-4656-8773-A14A0988E5F0Q26765455-486C9D53-5560-436E-98F9-56B0BEC8D23BQ26772302-7295653C-5FFB-46A3-B920-AE95CE8BFCF8Q26773198-4D4DDCC4-964B-4579-89B1-80C05AD87999Q26775340-E1DCB2D0-705F-42BC-ADF1-93FA0466BED3Q26775632-0A87565E-CD03-4E89-89C6-A7A6129D11BEQ26777147-4F86C756-3DA7-4F2F-BDAB-1D5858165FFFQ26780252-EABCB9E7-3A40-4122-B56C-F845A5B34605Q26780254-B453F6E2-83DC-4FBD-B28E-CB8470A3B316Q26781753-91D02E27-8FF8-4E43-8B7C-96064012D352Q26800894-6BCF9373-D3BC-4C68-B404-483722BB61DFQ26825269-A2EE7BBF-9347-4344-885F-0D94AB7078F4Q26827665-6E4E3AE6-B442-4E9C-8BAA-9D3EF062FA3DQ26828855-9275033A-4389-4612-A5E4-1F45F88472D9Q26829503-6FC99E16-4932-4AC2-A72B-E6BC8F7C1D4DQ26830594-9340BD18-3C9E-44DF-9C7C-08B5E5266B74Q26852019-AB06BBC5-E2C5-4C2E-B8DA-E66C2604F165Q26997059-3028EC7D-76F8-411D-B462-4CB973FEB35DQ26998471-E3E690EB-0246-4CAD-AD89-CF0C559A3796Q27006131-4DC98BCF-5ED5-4E24-A32F-E4378848DDF6Q27012600-60167627-BF96-4B73-8898-4DB8A7C9752EQ27021161-7D89387C-286E-45F5-8AA8-D784B3AF7A14Q27024352-6B6A3FF1-17DA-4C18-89C7-9D697E5B4677Q27335469-A69FDE8C-C26C-48CE-A2E2-8A256A722AB4Q27692035-0A078204-14C2-4569-BA5B-985ECFB114C4Q28071265-65D2B2F4-B595-4586-9D70-EBE8E4824714
P2860
Long-term follow-up of patients with NAFLD and elevated liver enzymes
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Long-term follow-up of patients with NAFLD and elevated liver enzymes
@ast
Long-term follow-up of patients with NAFLD and elevated liver enzymes
@en
type
label
Long-term follow-up of patients with NAFLD and elevated liver enzymes
@ast
Long-term follow-up of patients with NAFLD and elevated liver enzymes
@en
prefLabel
Long-term follow-up of patients with NAFLD and elevated liver enzymes
@ast
Long-term follow-up of patients with NAFLD and elevated liver enzymes
@en
P2093
P3181
P356
P1433
P1476
Long-term follow-up of patients with NAFLD and elevated liver enzymes
@en
P2093
Göran Bodemar
Lars Thorelius
Lennart E Franzén
Marika Holmqvist
Mattias Ekstedt
Ulrik L Mathiesen
P304
P3181
P356
10.1002/HEP.21327
P407
P577
2006-10-01T00:00:00Z